Current Retatrutide phase 3 clinical trials have proven 92% participants have lost 24-30% of total body weight in as little as 48 weeks
Most patients experience no adverse effects from using probiotics alongside semaglutide
Gallwitz B, Rosenstock J, Rauch T, Bhattacharya S, Patel S, von Eynatten M, Dugi KA, Woerle HJ: 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
Taste and adjust sweetness or acidity to preference
What it does not mean is better tolerance, better nutrition status, or better long-term outcomes for every individual